| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/12/2004 | EP1417214A2 Cancer specific oligosaccharide sequences and use thereof |
| 05/12/2004 | EP1416947A1 Fermentation medium and method |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | EP1226267B1 Process for producing a product containing antihypertensive tripeptides |
| 05/12/2004 | EP1112499B1 Method for detecting or quantifying basophils and eosinophils |
| 05/12/2004 | EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0785999B1 Plant transcription regulators from circovirus |
| 05/12/2004 | EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495259A Production of valuable compound by using chemically defined culture medium and adopting industrial scal fermentation process |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/12/2004 | CN1495196A Purification of human myocardium troponin I and preparation method of its monoclonal anti-body |
| 05/12/2004 | CN1495193A Recombinant humanized anti-hepatitis B surface antigen (HBs Ag) Fab antibody and its preparaticon method |
| 05/12/2004 | CN1149290C Novel Human Lysozyme gene, its encodling polypeptide and the method for preparing them |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/12/2004 | CN1149285C Expression of ocean fish antifreeze peptide in food grade organism and its application in food products |
| 05/12/2004 | CN1149279C Lactobacillus helveticus bacterium having capability of producing tripentide, fermented milk product, and preparing process thereof |
| 05/12/2004 | CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 05/11/2004 | US6734293 Novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734164 Addition of cysteine delays the temporal decrease in the effective concentration of the protein. the process is suitable for use in the production of heterologous proteins in microorganisms. |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734003 Phosphodiesterase 10 |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733980 Diagnostic method for detection of molecular forms of eosinophilic cationic protein (ISO-ECPS) |
| 05/11/2004 | US6733758 Fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 05/11/2004 | CA2045950C Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/06/2004 | WO2004038375A2 Water soluble toxin produced by pfiesteria species |
| 05/06/2004 | WO2004038034A1 Novel fructosyl peptide oxidase and utilization thereof |
| 05/06/2004 | WO2004038033A1 Defructosylation method |
| 05/06/2004 | WO2004038010A1 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 05/06/2004 | WO2004037982A2 High expression locus vector based on ferritin heavy chain gene locus |
| 05/06/2004 | WO2004037863A1 Antibody and utilization of the same |
| 05/06/2004 | WO2004021992A9 Delivery of therapeutics to the brain and spinal cord |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2003064469A8 Regulation of human hematopoietin receptor-like protein |
| 05/06/2004 | WO2003048189A3 Products of manufacture and processes for peptide synthesis |
| 05/06/2004 | WO2003031567A9 Precursor conversion screening methods |
| 05/06/2004 | WO2003009817A9 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 05/06/2004 | WO2002091995A8 Method to induce neovascular formation and tissue regeneration |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002074251A9 Monoclonal antibody therapy for pancreas cancer |
| 05/06/2004 | US20040088756 Identifying diseases resistance gene in plants |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087775 Process for production diphtheria toxin |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/06/2004 | US20040087532 Vaccine comprising antigen presenting cells loaded with at least two tumor antigens and/or tumor antigen derived peptides |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040087503 Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087478 Discovering pain regulating substances; incubating with then measuring binding to cell synthesized peptide or protein |
| 05/06/2004 | US20040086998 Comprises nucleotide sequences coding regulatory elements and protein with trehalose-6-phosphate synthase activity for transformation and expression in yeast; heterologous gene expression and bioreactors |
| 05/06/2004 | US20040086979 Preparing monoclonal antibody with reduced immunogenicity; diagnostic tools; immunotherapy |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders |
| 05/06/2004 | US20040086969 Expressing heterologous polypeptides in rhodospirillum; bioreactors; vaccine development |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086962 Methods and materials relating to gene expression |
| 05/06/2004 | US20040086961 Amino acid modified polypeptides |
| 05/06/2004 | US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy |
| 05/06/2004 | US20040086959 Using in vitro translation to generation heterologous proteins; bioreactors |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086938 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 05/06/2004 | US20040086931 Polypeptides and nucleic acids encoding same |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086913 Human genes and gene expression products XVI |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086902 Comprises nucleotide sequences coding fructosyltransferase for preparation of fructooligosaccharides and difructose dianhydrides for use as dietetic food or animal feed additive |
| 05/06/2004 | US20040086900 Generating transgenic yeast coding heterologous phosphodiesterase for identifying modulators for treatment of cardiovascular, asthma, depression and thrombotic disorders |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086507 Antibody inhibiting vplf activity |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | EP1416280A2 Antibodies specific for native PrPsc |
| 05/06/2004 | EP1416272A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson's disease |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | EP1415005A2 Endogenous retroviruses up-regulated in prostate cancer |
| 05/06/2004 | EP1414988A1 Method for preparing ester linked peptide-carbohydrate conjugates |
| 05/06/2004 | EP1414978A1 Novel recombinant gene expression method by stop codon suppression |